• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病连续体中阿尔茨海默病生物标志物和危险因素对认知障碍和衰退的贡献。

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.

机构信息

San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.

出版信息

Alzheimers Dement. 2022 Jul;18(7):1370-1382. doi: 10.1002/alz.12480. Epub 2021 Oct 14.

DOI:10.1002/alz.12480
PMID:34647694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9014819/
Abstract

INTRODUCTION

Amyloid beta (Aβ), tau, and neurodegeneration jointly with the Alzheimer's disease (AD) risk factors affect the severity of clinical symptoms and disease progression.

METHODS

Within 248 Aβ-positive elderly with and without cognitive impairment and dementia, partial least squares structural equation pathway modeling was used to assess the direct and indirect effects of imaging biomarkers (global Aβ-positron emission tomography [PET] uptake, regional tau-PET uptake, and regional magnetic resonance imaging-based atrophy) and risk-factors (age, sex, education, apolipoprotein E [APOE], and white-matter lesions) on cross-sectional cognitive impairment and longitudinal cognitive decline.

RESULTS

Sixteen percent of variance in cross-sectional cognitive impairment was accounted for by Aβ, 46% to 47% by tau, and 25% to 29% by atrophy, although 53% to 58% of total variance in cognitive impairment was explained by incorporating mediated and direct effects of AD risk factors. The Aβ-tau-atrophy pathway accounted for 50% to 56% of variance in longitudinal cognitive decline while Aβ, tau, and atrophy independently explained 16%, 46% to 47%, and 25% to 29% of the variance, respectively.

DISCUSSION

These findings emphasize that treatments that remove Aβ and completely stop downstream effects on tau and neurodegeneration would only be partially effective in slowing of cognitive decline or reversing cognitive impairment.

摘要

简介

β淀粉样蛋白(Aβ)、tau 蛋白和神经退行性变与阿尔茨海默病(AD)的危险因素共同影响临床症状的严重程度和疾病进展。

方法

在 248 名 Aβ 阳性的老年认知障碍和痴呆患者中,使用偏最小二乘结构方程路径模型评估了影像学生物标志物(全脑 Aβ 正电子发射断层扫描 [PET] 摄取、tau-PET 摄取的区域和基于区域磁共振成像的萎缩)和危险因素(年龄、性别、教育、载脂蛋白 E [APOE]和白质病变)对横断面认知障碍和纵向认知下降的直接和间接影响。

结果

横断面认知障碍的 16%可以由 Aβ解释,46%至 47%可以由 tau 解释,25%至 29%可以由萎缩解释,尽管纳入 AD 危险因素的中介和直接效应可以解释认知障碍总方差的 53%至 58%。Aβ-tau-萎缩途径解释了纵向认知下降的 50%至 56%,而 Aβ、tau 和萎缩独立解释了 16%、46%至 47%和 25%至 29%的方差。

讨论

这些发现强调,去除 Aβ 并完全阻止其对 tau 和神经退行性变的下游影响的治疗方法,只能在减缓认知下降或逆转认知障碍方面起到部分作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666c/9542498/d4e28cbadcfd/ALZ-18-1370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666c/9542498/d4e28cbadcfd/ALZ-18-1370-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666c/9542498/d4e28cbadcfd/ALZ-18-1370-g003.jpg

相似文献

1
Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.阿尔茨海默病连续体中阿尔茨海默病生物标志物和危险因素对认知障碍和衰退的贡献。
Alzheimers Dement. 2022 Jul;18(7):1370-1382. doi: 10.1002/alz.12480. Epub 2021 Oct 14.
2
Contribution of Alzheimer's disease pathology to biological and clinical progression: A longitudinal study across two cohorts.阿尔茨海默病病理学对生物学和临床进展的贡献:两个队列的纵向研究。
Alzheimers Dement. 2023 Aug;19(8):3602-3612. doi: 10.1002/alz.12992. Epub 2023 Feb 25.
3
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
4
Measures of cortical microstructure are linked to amyloid pathology in Alzheimer's disease.皮质微结构测量与阿尔茨海默病中的淀粉样蛋白病理学有关。
Brain. 2023 Apr 19;146(4):1602-1614. doi: 10.1093/brain/awac343.
5
APOE effects on regional tau in preclinical Alzheimer's disease.载脂蛋白 E 对临床前阿尔茨海默病中 tau 蛋白的区域性影响。
Mol Neurodegener. 2023 Jan 4;18(1):1. doi: 10.1186/s13024-022-00590-4.
6
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
7
Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.糖酵解系统功能障碍可预测阿尔茨海默病中的淀粉样蛋白沉积、神经退行性变和临床进展。
Alzheimers Dement. 2024 May;20(5):3251-3269. doi: 10.1002/alz.13789. Epub 2024 Mar 19.
8
Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.病理性和容积性生物标志物变化与临床正常成年人认知能力下降的关联。
Neurology. 2023 Dec 12;101(24):e2533-e2544. doi: 10.1212/WNL.0000000000207962. Epub 2023 Nov 8.
9
Amyloid-β but not tau accumulation is strongly associated with longitudinal cognitive decline.淀粉样蛋白-β而非 tau 积聚与纵向认知能力下降密切相关。
CNS Neurosci Ther. 2024 Jul;30(7):e14860. doi: 10.1111/cns.14860.
10
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.血浆神经丝轻链与阿尔茨海默病影像学生物标志物的阶段特异性关联。
Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342.

引用本文的文献

1
Ante-mortem cognitive trajectories associated with Aβ and tau biomarker profiles in older adults with cerebrovascular disease: a longitudinal cohort study.患有脑血管疾病的老年人中与淀粉样蛋白β和tau生物标志物谱相关的生前认知轨迹:一项纵向队列研究。
Alzheimers Res Ther. 2025 Jul 18;17(1):165. doi: 10.1186/s13195-025-01776-w.
2
Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease.阿尔茨海默病中tau蛋白的纵向聚集、萎缩及认知衰退
Alzheimers Dement. 2025 Jul;21(7):e70435. doi: 10.1002/alz.70435.
3
Multimodal and longitudinal characterization of distinct tau and atrophy clusters in Alzheimer's disease spectrum.

本文引用的文献

1
Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults.基线认知能力是认知正常的老年人 4 年内认知变化的最佳预测指标。
Alzheimers Res Ther. 2021 Apr 7;13(1):75. doi: 10.1186/s13195-021-00798-4.
2
Adding cognition to AT(N) models improves prediction of cognitive and functional decline.将认知因素纳入AT(N)模型可改善对认知和功能衰退的预测。
Alzheimers Dement (Amst). 2021 Mar 31;13(1):e12174. doi: 10.1002/dad2.12174. eCollection 2021.
3
To what degree is late life cognitive decline driven by age-related neuropathologies?
阿尔茨海默病谱系中不同tau蛋白和萎缩簇的多模态纵向特征分析。
Sci Rep. 2025 May 25;15(1):18142. doi: 10.1038/s41598-025-98338-9.
4
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's disease.一种用于预测阿尔茨海默病认知恢复力与认知衰退的脑脊液突触蛋白生物标志物。
Nat Med. 2025 May;31(5):1592-1603. doi: 10.1038/s41591-025-03565-2. Epub 2025 Mar 31.
5
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.散发性早发型与晚发型阿尔茨海默病中的淀粉样蛋白PET:LEADS和ADNI队列的比较
Ann Neurol. 2025 Aug;98(2):236-248. doi: 10.1002/ana.27233. Epub 2025 Mar 17.
6
Measurement Error and Methodologic Issues in Analyses of the Proportion of Variance Explained in Cognition.认知中解释方差比例分析的测量误差与方法学问题
Neuropsychol Rev. 2024 Nov 20. doi: 10.1007/s11065-024-09655-1.
7
White matter hyperintensity on MRI and plasma Aβ42/40 ratio additively increase the risk of cognitive impairment in hypertensive adults.MRI 上的脑白质高信号和血浆 Aβ42/40 比值相加会增加高血压成年人认知障碍的风险。
Alzheimers Dement. 2024 Oct;20(10):6810-6819. doi: 10.1002/alz.14126. Epub 2024 Sep 4.
8
Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity.有淀粉样β蛋白阳性的认知正常老年人认知下降的危险因素。
Alzheimers Res Ther. 2024 Aug 19;16(1):189. doi: 10.1186/s13195-024-01554-0.
9
Impact of Helicobacter pylori eradication on age-specific risk of incident dementia in patients with peptic ulcer disease: a nationwide population-based cohort study.幽门螺杆菌根除对消化性溃疡病患者特定年龄痴呆发病风险的影响:一项基于全国人群的队列研究。
Geroscience. 2025 Feb;47(1):1161-1174. doi: 10.1007/s11357-024-01284-z. Epub 2024 Aug 12.
10
The concept of resilience to Alzheimer's Disease: current definitions and cellular and molecular mechanisms.阿尔茨海默病的弹性概念:当前的定义和细胞及分子机制。
Mol Neurodegener. 2024 Apr 8;19(1):33. doi: 10.1186/s13024-024-00719-7.
老年认知衰退在多大程度上是由与年龄相关的神经病理学引起的?
Brain. 2021 Aug 17;144(7):2166-2175. doi: 10.1093/brain/awab092.
4
Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology.纵向认知和生物标志物测量支持阿尔茨海默病病理生理学中的单向途径。
Biol Psychiatry. 2021 Apr 15;89(8):786-794. doi: 10.1016/j.biopsych.2020.06.029. Epub 2020 Jul 12.
5
Alzheimer's disease drug development pipeline: 2020.2020年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2020 Jul 16;6(1):e12050. doi: 10.1002/trc2.12050. eCollection 2020.
6
β-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline.β-淀粉样蛋白和 tau 驱动早发性阿尔茨海默病的衰退,而葡萄糖代谢低下则驱动晚发性衰退。
Commun Biol. 2020 Jul 6;3(1):352. doi: 10.1038/s42003-020-1079-x.
7
Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.小胶质细胞激活和 tau 负担可预测阿尔茨海默病的认知能力下降。
Brain. 2020 May 1;143(5):1588-1602. doi: 10.1093/brain/awaa088.
8
Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.评估与阿尔茨海默病患者病理性 Tau 相关的脑储备和认知储备的人口统计学、遗传学和影像学变量。
JAMA Neurol. 2020 May 1;77(5):632-642. doi: 10.1001/jamaneurol.2019.5154.
9
Late-life cognitive decline is associated with hippocampal volume, above and beyond its associations with traditional neuropathologic indices.老年认知衰退与海马体体积有关,而不仅仅与其与传统神经病理学指标的关联有关。
Alzheimers Dement. 2020 Jan;16(1):209-218. doi: 10.1002/alz.12009.
10
Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan.跨生命周期大脑影像模式分析中大 MRI 数据集的协调。
Neuroimage. 2020 Mar;208:116450. doi: 10.1016/j.neuroimage.2019.116450. Epub 2019 Dec 9.